Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
Blood test may help tailor lung cancer therapy
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab improves survival in people with advanced non-small cell lung cancer. About 63 participants with high PD-L1 levels will receive cemiplimab first, and …
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Lung cancer clues: old data may reveal best Pre-Surgery treatments
Knowledge-focused Recruiting nowThis study reviews medical records from 150 people with stage IIIA lung cancer who had chemotherapy before surgery. Researchers want to see if the amount of tumor killed by treatment predicts how long patients live without cancer coming back. No new treatments are given; the goal…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Lung cancer study tracks immune response after standard treatment
Knowledge-focused Recruiting nowThis study observes how the immune system responds after standard treatment for advanced lung cancer. Researchers will review medical records of 50 patients with stage III non-small cell lung cancer who received chemo-radiation followed by immunotherapy. The goal is to understand…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC